Low free triiodothyronine and immune-related hyperthyroidism are associated with overall and progression-free survival in head and neck squamous cell carcinoma treated with pembrolizumab
- Resource Type
- Article
- Source
- In
International Immunopharmacology October 2023 123 - Subject
- Language
- ISSN
- 1567-5769